End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.89 CNY | -2.30% | +1.36% | -1.65% |
Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.05B 559M | Sales 2025 * | 4.69B 648M | Capitalization | 17.81B 2.46B |
---|---|---|---|---|---|
Net income 2024 * | 2.33B 322M | Net income 2025 * | 2.69B 372M | EV / Sales 2024 * | 4.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.8 x |
P/E ratio 2024 * |
7.68
x | P/E ratio 2025 * |
6.63
x | Employees | 5,646 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.41% |
1 day | -2.30% | ||
1 week | +1.36% | ||
Current month | +2.97% | ||
1 month | +2.97% | ||
3 months | +1.29% | ||
6 months | -9.70% | ||
Current year | -1.65% |
Managers | Title | Age | Since |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 99-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 93-01-31 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 14.89 | -2.30% | 22,372,190 |
24-04-29 | 15.24 | +1.06% | 22,075,880 |
24-04-26 | 15.08 | +2.65% | 23,697,950 |
24-04-25 | 14.69 | -0.61% | 8,121,685 |
24-04-24 | 14.78 | +0.14% | 8,104,715 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.65% | 2.46B | |
+34.00% | 704B | |
+27.40% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.42% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- 000623 Stock